Literature DB >> 23100923

Hematological profile of sickle cell disease in central India.

A V Shrikhande1, A A Dani, J R Tijare, A K Agrawal.   

Abstract

Hematological profile of homozygous sickle cell disease patients attending RHDMC from Central India is presented. Central India has a huge population of sickle cell disease patients. Though predicted SS in the region is 22-44 %, 81 homozygous of sickle cell patients reported during study period of Jan 2003-Dec 2005. The clinical course of these patients is characterized in most of the cases by relatively long period without any symptoms punctuated by acute clinical events. Hematological profile of these 81 patients with age ranging from 6 month to 64 years is presented. There are 44 males and 37 females with an average age of 14.55yrs in males and 18.13 yrs females. Males out number females in pediatric age group where as females with SCD are attending hospital more in reproductive age group. Very few patients are reported after the age of 30 yrs. Average hemoglobin in males is 7.11 ± 2.13 gms/dl and in females 6.75 ± 1.85 gms/dl with parallel low RBC count.Hemoglobin rise is seen after 14 years of age in males and females. Age related rise in MCV is more noted in females after the age of 5 as compared to males. No age or sex related difference was seen in MCHC values. Hb A(2) levels for males is 2.13 ± 0.95% and for females 2.04 ± 0.91 %.Hb F in males is 19.58 + 5.86% and in females is 20.99 + 4.9%. There is no age and sex related difference in Hb F levels. Moderate to severe anemia with high Hb F dominate Central Indian sickle cell disease patient's hematological profile. The hematological profile in Central India is similar to the profile in other parts of India and Saudi Arabia but different from Jamaica and Africa.

Entities:  

Keywords:  Central India; HPLC; Hematological profile; Sickle cell disease

Year:  2008        PMID: 23100923      PMCID: PMC3453122          DOI: 10.1007/s12288-008-0005-z

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  10 in total

Review 1.  Fetal haemoglobin in homozygous sickle cell disease.

Authors:  G R Serjeant
Journal:  Clin Haematol       Date:  1975-02

2.  Sickle-cell trait in Central India.

Authors:  R N SHUKLA; B R SOLANKI
Journal:  Lancet       Date:  1958-02-08       Impact factor: 79.321

3.  Sickle cell disease in Orissa State, India.

Authors:  B C Kar; R K Satapathy; A E Kulozik; M Kulozik; S Sirr; B E Serjeant; G R Serjeant
Journal:  Lancet       Date:  1986-11-22       Impact factor: 79.321

4.  Sickle cell trait & disease among tribal communities in Orissa, Madhya Pradesh & Kerala.

Authors:  M Kaur; G P Das; I C Verma
Journal:  Indian J Med Res       Date:  1997-03       Impact factor: 2.375

5.  The haematology of steady state homozygous sickle cell disease: frequency distributions, variation with age and sex, longitudinal observations.

Authors:  R J Hayes; M Beckford; Y Grandison; K Mason; B E Serjeant; G R Serjeant
Journal:  Br J Haematol       Date:  1985-02       Impact factor: 6.998

6.  The haematological response to androgens in sickle cell anaemia.

Authors:  B Lundh; F H Gardner
Journal:  Scand J Haematol       Date:  1970

7.  Post-natal decline of fetal haemoglobin in homozygous sickle cell disease: relationship to parenteral Hb F levels.

Authors:  K P Mason; Y Grandison; R J Hayes; B E Serjeant; G R Serjeant; S Vaidya; W G Wood
Journal:  Br J Haematol       Date:  1982-11       Impact factor: 6.998

8.  alpha-Thalassemia reduces the hemolytic rate in homozygous sickle-cell disease.

Authors:  K de Ceulaer; D R Higgs; D J Weatherall; R J Hayes; B E Serjeant; G R Serjeant
Journal:  N Engl J Med       Date:  1983-07-21       Impact factor: 91.245

Review 9.  Renal failure in sickle cell anemia.

Authors:  W Y Wong; D Elliott-Mills; D Powars
Journal:  Hematol Oncol Clin North Am       Date:  1996-12       Impact factor: 3.722

10.  A population study of renal function in sickle cell anemia.

Authors:  A H Sklar; H Campbell; R J Caruana; B O Lightfoot; J G Gaier; P Milner
Journal:  Int J Artif Organs       Date:  1990-04       Impact factor: 1.595

  10 in total
  5 in total

1.  Sickle Cell Disease in Central India: A Potentially Severe Syndrome.

Authors:  Dipty Jain; Vinit Warthe; Paridhi Dayama; Dilip Sarate; Roshan Colah; Pallavi Mehta; Graham Serjeant
Journal:  Indian J Pediatr       Date:  2016-04-07       Impact factor: 1.967

2.  A demographic prevalence of β Thalassemia carrier and other hemoglobinopathies in adolescent of Tharu population.

Authors:  Nitu Nigam; Rashmi Kushwaha; Geeta Yadav; Prithvi K Singh; Nitin Gupta; Bhupendra Singh; Monica Agrawal; Pooran Chand; Shailedra K Saxena; Madan Lal Brahma Bhatt
Journal:  J Family Med Prim Care       Date:  2020-08-25

3.  Hematological profile of sickle cell disease from South Gujarat, India.

Authors:  Sanjeev Shyam Rao; Jagdish Prasad Goyal; S V Raghunath; Vijay B Shah
Journal:  Hematol Rep       Date:  2012-05-22

4.  Patterns and patient factors associated with loss to follow-up in the Muhimbili sickle cell cohort, Tanzania.

Authors:  Upendo Masamu; Raphael Z Sangeda; Daniel Kandonga; Jesca Ondengo; Flora Ndobho; Bruno Mmbando; Siana Nkya; Khadija Msami; Julie Makani
Journal:  BMC Health Serv Res       Date:  2020-12-14       Impact factor: 2.655

Review 5.  Epidemiology & social costs of haemophilia in India.

Authors:  Anita Kar; Supriya Phadnis; Sumedha Dharmarajan; Juhi Nakade
Journal:  Indian J Med Res       Date:  2014-07       Impact factor: 2.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.